AN INTERIM ANALYSIS OF THE EFFICACY AND SAFETY OF LUSPATERCEPT IN COMBINATION WITH RECOMBINANT HUMAN ERYTHROPOIETIN IN THE TREATMENT OF LOW-RISK MYELODYSPLASTIC SYNDROME WITH ANEMIA

EHA Library, Chao Hu, 4161829

REAL-WORLD OUTCOMES OF PATIENTS WITH LOWER-RISK MYELODYSPLASTIC SYNDROME RECEIVING FIRST-LINE LUSPATERCEPT OR FIRST-LINE ERYTHROPOIESIS-STIMULATING AGENTS IN THE US

EHA Library, Idoroenyi Amanam, 4161830

RENEW TRIAL IN PROGRESS: A PHASE 3, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE ELRITERCEPT IN PARTICIPANTS WITH TRANSFUSION-DEPENDENT ANEMIA AND LOWER-RISK MYELODYSPLASTIC NEOPLASMS

EHA Library, Rami S. Komrokji, 4161831

GENOMIC LANDSCAPE AND CLINICAL OUTCOMES OF CHILDREN WITH ADVANCED MYELODYSPLASTIC SYNDROMES

EHA Library, chenmeng Liu, 4161832

LUSPATERCEPT FOR THE TREATMENT OF TRANSFUSION-DEPENDENT ANEMIA IN PATIENTS WITH MYELODYSPLASTIC NEOPLASMS WITH DEL5Q, REFRACTORY/RESISTANT/INTOLERANT TO PRIOR TREATMENTS (QOL-ONE PHOENIX)

EHA Library, Esther N. Oliva, 4161833

CHARACTERIZATION AND MANAGEMENT OF TRANSIENT CYTOPENIAS ASSOCIATED WITH IMETELSTAT (IME) IN LOWER-RISK MYELODYSPLASTIC SYNDROMES (LR-MDS) FROM THE IMERGE TRIAL

EHA Library, Amer M. Zeidan, 4161834

HIGH DOSE ASCORBATE REDUCES INTERLEUKIN-1 BETA SECRETION IN TET2 MUTANT MONOCYTES AND DEMONSTRATES EXCELLENT SAFETY AND TOLERABILITY IN CMML PATIENTS IN COMBINATION WITH AZACITIDINE

EHA Library, Daniel Thomas, 4161835

A NOVEL HOMOZYGOUS OSM MUTATION: FROM BONE MARROW FAILURE TO MYELOID NEOPLASM, A REPORT OF THREE CASES.

EHA Library, Alfadil Haroon, 4161836

DANAZOL IN THE TREATMENT OF IDIOPATHIC CYTOPENIA OF UNDETERMINED SIGNIFICANCE(ICUS): A SINGLE-CENTER, SINGLE-ARM RETROSPECTIVE STUDY

EHA Library, Siyuan Cui, 4161837

EXPOSURE-RESPONSE ANALYSES OF VENETOCLAX COMBINED WITH HYPOMETHYLATING AGENTS IN MYELODYSPLASTIC SYNDROMES

EHA Library, Jixin Tian, 4161838

PHASE 3 STUDY OF EITHER IVOSIDENIB MONOTHERAPY OR AZACITIDINE MONOTHERAPY IN PATIENTS WITH IDH1 MUTANT MYELODYSPLASTIC SYNDROMES WHO ARE HYPOMETHYLATING AGENT NAIVE (PYRAMIDH)

EHA Library, Marie Sébert, 4161839

DYNAMICS OF VEGF AND PROLIFERATIVE ACTIVITY OF STEM CELLS IN MYELODYSPLASTIC SYNDROME

EHA Library, Halyna Starodub, 4161840

THE RELATIONSHIP BETWEEN NUTRITION, HEMOGLOBIN, AND FRAILTY IN ELDERLY PATIENTS WITH MYELODYSPLASTIC SYNDROMES: A MEDIATION EFFECT ANALYSIS

EHA Library, Jinying Zhao, 4161841

EARLY COLONIZATION WITH ANTIBIOTIC-RESISTANT BACTERIA MIGHT INFLUENCE THE SURVIVAL OF PATIENTS TREATED WITH 5-AZA: A SINGLE-CENTER RETROSPECTIVE STUDY.

EHA Library, Karol Lis, 4161842

SOCIOECONOMIC AND DEMOGRAPHIC DISPARITIES IN OUTCOMES OF PATIENTS WITH MYELODYSPLASTIC SYNDROME: A TWO DECADE NATIONWIDE ANALYSIS

EHA Library, Asfand Yar Cheema, 4161843

PREVALENCE OF AGING-RELATED COMORBIDITIES IN MYELODYSPLASTIC SYNDROMES: A SYSTEMATIC REVIEW AND META-ANALYSIS

EHA Library, Ioannis Kotsianidis, 4161844

ADDITIONAL PROGNOSTIC VALUE OF ABSOLUTE MONOCYTE AND ABSOLUTE LYMPHOCYTE COUNTS IN MYELODYSPLASTIC SYNDROME INDEPENDENTLY FROM THE IPSS-R SCORE

EHA Library, Marijana Virijevic, 4161845

TRIAL IN PROGRESS: AN INTERNATIONAL, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER PHASE 2 STUDY OF AK117/PLACEBO IN COMBINATION WITH AZACITIDINE IN PATIENTS WITH NEWLY DIAGNOSED HIGHER-RISK MYELODYSPLASTIC SYNDROMES (AK117-205)

EHA Library, Amer M. Zeidan, 4161846

TRIAL IN PROGRESS: MIDAS - A PHASE 2, RANDOMIZED, OPEN-LABEL STUDY OF MOMELOTINIB IN PATIENTS WITH ANEMIA DUE TO LOWER-RISK MYELODYSPLASTIC SYNDROMES

EHA Library, Guillermo Garcia-Manero, 4161847

EFFICACY AND OUTCOMES OF NOVEL THERAPEUTIC AGENTS AS MONOTHERAPY OR IN COMBINATION WITH CONVENTIONAL THERAPY IN MYELODYSPLASTIC SYNDROME: A SYSTEMATIC REVIEW AND META-ANALYSIS

EHA Library, Moazzam Shahzad, 4161848

PATIENT AND DISEASE CHARACTERISTICS ASSOCIATED WITH FIRST-LINE HMA THERAPY IN HIGH RISK-MDS: A RETROSPECTIVE ANALYSIS

EHA Library, Hatem Ellaithy, 4161849

ASXL1 MUTATIONS DETERMINE INFERIOR OUTCOME IN LOWER-RISK MYELODYSPLASTIC SYNDROMES: MONOCENTRIC REAL-LIFE DATA

EHA Library, Daniela Barraco, 4161851

IMPACT OF AZACYTIDINE ON COGNITIVE FUNCTION IN MYELODYSPLASTIC SYNDROMES: PRELIMINARY FINDINGS FROM A PROSPECTIVE SINGLE-CENTER COHORT STUDY

EHA Library, Ioannis Kotsianidis, 4161852

CHART REVIEW STUDY ON DOSE MODIFICATIONS OF PATIENTS WITH MYELODYSPLASTIC SYNDROME TREATED WITH HYPOMETHYLATING AGENTS

EHA Library, Yuexi Wang, 4161853

COMPARISON OF THE PROGNOSTIC SCORE AIPSS-MDS VS. CPSS AND CPSS-MOL IN A COHORT OF PATIENTS WITH CHRONIC MYELOMONOCYTIC LEUKEMIA: A SINGLE-CENTER EXPERIENCE

EHA Library, Juan Francisco Lopez Rodriguez, 4161854

EVALUATION OF ELIGLUSTAT THERAPY IN PATIENTS WITH GAUCHER DISEASE TYPE 1: A SINGLE CENTER EXPERIENCE

EHA Library, Veroniki Komninaka, 4161855

TREATMENT OF HIGH-RISK MYELODYSPLASTIC SYNDROME (HR MDS) AND ACUTE MYELOGENOUS LEUKEMIA WITH MDS RELATED CHANGES (AML MRC) WITH HIGH BURDEN TP53 MUTATION (VAF≥ 10%)

EHA Library, Maher Salamoon, 4161856

THE PROGNOSTIC POTENTIAL OF HALP SCORE IN MYELODYSPLASTIC SYNDROMES - A SINGLE INSTITUTION EXPERIENCE IN A REAL-WORLD SETTING

EHA Library, Emil Aleksov, 4161857

USING ONLINE CONTINUING MEDICAL EDUCATION INITIATIVES TO IDENTIFY ONGOING GAPS IN CLINICIANS' ABILITY TO MANAGE MYELODYSPLASTIC SYNDROME

EHA Library, Sarah Elizabeth Bomba, 4161858

INDUCTION CHEMOTHERAPY WITH HIGH-DOSE CYTARABINE FOLLOWED BY LENALIDOMIDE AND AZACITIDINE IN VERY HIGH RISK MYELODYSPLASTIC SYNDROME (HR MDS)

EHA Library, Maher Salamoon, 4161859

COMPARISON OF CYCLOSPORINE PLUS ELTROMBOPAG WITH OR WITHOUT ANTI-THYMOCYTE IMMUNOGLOBULIN IN NEWLY DIAGNOSED SEVERE APLASTIC ANEMIA: A SINGLE-CENTER RETROSPECTIVE STUDY

EHA Library, Bing Han, 4161860

SINGLE CELL RNA-SEQ IDENTIFIES LUSPATERCEPT COULD SERVE AS A NOVEL THERAPEUTIC DRUG FOR APLASTIC ANEMIA

EHA Library, Zining Wang, 4161861

RUXOLITINIB MAY TREAT APLASTIC ANAEMIA BY REDUCING LEVELS OF MACROPHAGE PYROPTOSIS

EHA Library, Xintong Xu, 4161862

RESEARCH ON THE EFFECT OF LUSPATERCEPT AND ERYTHROPOIETIN ON ERYTHROID DIFFERENTIATION IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA

EHA Library, Rong Fu, 4161863

EFFICACY OF COMPLEMENT INHIBITORS AND HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: A META ANALYSIS AND SYSTEMATIC REVIEW

EHA Library, Rong Fu, 4161864

LOW-DOSE CHLOROQUINE EXHIBITS SUPPRESSION OF CTLS MEDIATED BY NK CYTOTOXICITY IN SEVERE APLASTIC ANEMIA

EHA Library, Tong Chen, 4161865

A REAL-WORLD, MULTI-CENTER, PROSPECTIVE, OBSERVATIONAL STUDY FOR PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA (PNH) IN CHINA: PRELIMINARY RESULTS

EHA Library, Rong Fu, 4161867

DOSE DETERMINATION FOR A RARE INDICATION: PHASE 3 DOSE OF ZALTENIBART, AN INVESTIGATIONAL MASP-3 INHIBITOR, FOR TREATMENT OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH)

EHA Library, William Pullman, 4161868

LP-005, A BIFUNCTIONAL C5 ANTIBODY FUSION PROTEIN, EFFECTIVELY CONTROLS BOTH HEMOLYSIS: INTERIM RESULTS FROM A PHASE 2 STUDY

EHA Library, Guangsheng He, 4161869

COMPREHENSIVE ANALYSIS OF THE CLINICAL FEATURE, MYELOID NEOPLASM-RELATED GENE MUTATION PROFILES AND T CELL DIVERSITY IN 168 PATIENTS WITH ACQUIRED PURE RED CELL APLASIA

EHA Library, Guangsheng He, 4161870

A STUDY ON FLUDARABINE, CYCLOPHOSPHAMIDE, AND MELPHALAN (FCM) PRECONDITIONING IN HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR SEVERE APLASTIC ANEMIA: A PROSPECTIVE, MULTICENTER, SINGLE-ARM CLINICAL STUDY

EHA Library, Xiaoping Li, 4161871

EFFICACY OF FULMINANT APLASTIC ANEMIA TO INTENSIVE IMMUNOSUPPRESSIVE THERAPY (IST) IS INFERIOR TO THAT OF SEVERE APLASTIC ANEMIA, VERY SEVERE APLASTIC ANEMIA: A PROSPECTIVE REGISTRY STUDY REPORT

EHA Library, Guangsheng He, 4161872

A SINGLE INSTITUTION EXPERIENCE OF IPTACOPAN IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA

EHA Library, Mark Orland, 4161873

NETWORK META-ANALYSIS COMPARING THE EFFICACY OF DIFFERENT COMPLEMENT PATHWAY INHIBITORS FOR THE TREATMENT OF PAROXYSMAL NOCTURNAL HEMATURIA

EHA Library, Eri Matsuki, 4161874

PROLONGED USE OF LOW DOSAGE ELTROMBOPAG IN CHINESE PATIENTS WITH SEVERE APLASTIC ANEMIA IN THE REAL WORLD

EHA Library, Guangsheng He, 4161875

ANALYSIS OF TELOMERE LENGTH DYNAMICS IN PATIENTS WITH APLASTIC ANEMIA DURING IMMUNISUPRESSIVE THERAPY

EHA Library, Anton luchkin, 4161876

APLASTIC ANAEMIA: 10 YEAR OUTCOMES IN A SOUTH AFRICAN TRANSPLANT CENTRE.

EHA Library, Marthinus Dicks, 4161877

ASSESSMENT OF LONG-TERM RENAL FUNCTION IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA TREATED WITH RAVULIZUMAB IN A PHASE 3 OPEN-LABEL STUDY

EHA Library, Srikanth Nagalla, 4161878

HEMATOLOGIC FEATURES OF VEXAS SYNDROME IN MEXICAN PATIENTS: A RETROSPECTIVE STUDY

EHA Library, Lyam Carlo Chacon-Rangel, 4161879

OBTAINING INSIGHTS ON PNH MANAGEMENT WITH IPTACOPAN IN EVERYDAY CLINICAL PRACTICE: A RESEARCH COLLABORATION WITH THE IPIG PNH REGISTRY

EHA Library, Richard J Kelly, 4161880

ASSESSMENT OF CHARACTERISTICS AND TREATMENT PATTERNS OF ADULT PATIENTS WITH ACQUIRED APLASTIC ANAEMIA IN TURKIYE (PLANE-TR STUDY)

EHA Library, Eren Gunduz, 4161881

EVALUATION OF HAEMATOLOGY PHYSICIANS' AWARENESS OF AND REFERRAL TO APLASTIC ANAEMIA PATIENT ADVOCACY GROUPS

EHA Library, Fabian Beier, 4161882

ENHANCING OUTCOMES IN HEPATITIS-ASSOCIATED APLASTIC ANEMIA: THE ROLE OF THROMBOPOIETIN RECEPTOR AGONISTS AS AN ADJUNCT TO STANDARD IMMUNOSUPPRESSIVE THERAPY

EHA Library, Meili Ge, 4161883

SINGLE-CENTER RETROSPECTIVE ANALYSIS OF DIFFERENT THROMBOPOIESIS-STIMULATING THERAPY REGIMENS IN SEVERE APLASTIC ANEMIA

EHA Library, Rong Fu, 4161884

LONG-TERM SAFETY OF SB12 IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: UP TO 2-YEAR EXTENSION TREATMENT SAFETY DATA

EHA Library, Jun Ho Jang, 4161885

SYSTEMATIC MAPPING OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA RESOURCES: IDENTIFYING GAPS IN CLINICAL EDUCATION TOOLS TO IMPROVE DIAGNOSIS AND PATIENT CARE

EHA Library, Gulin Kayserili, 4161886

A SINGLE CENTER REAL-WORLD STUDY ON THE EFFICACY AND RECOVERY OF INFLAMMATORY CYTOKINE LEVELS OF C5 COMPLEMENT INHIBITOR THERAPY IN PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA PATIENTS

EHA Library, Rong Fu, 4161887

THE PREDICTIVE VALUE OF NUTRITIONAL STATUS AND BLOOD INDICES FOR ADVERSE REACTIONS IN IMMUNOSUPPRESSIVE THERAPY FOR APLASTIC ANEMIA PATIENTS

EHA Library, LI Xinli, 4161888

POSITIVE ANTI-NEUTROPHIL ANTIBODIES IN EARLY CHILDHOOD MAY BE DETECTED IN ENTITIES OTHER THAN PRIMARY AUTOIMMUNE NEUTROPENIA.

EHA Library, Konstantina Toutoudaki, 4161889

TREATMENT BURDEN IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) TREATED WITH INTRAVENOUS C5 INHIBITORS: AN IN-DEPTH INTERVIEW SURVEY STUDY

EHA Library, Naoshi Obara, 4161890

COMBINATION OF CYCLOSPORINE AND ELTROMBOPAG AS A FIRST LINE THERAPY IN PATIENTS WITH APLASTIC ANEMIA: A SINGLE CENTER EXPERIENCE FROM A DEVELOPING NATION.

EHA Library, Aritra Saha, 4161891

CONSENSUS ALGORITHM FOR SCREENING AND DIAGNOSIS OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA IN GREECE: INSIGHTS FROM A MULTI-SPECIALTY EXPERT DELPHI-PANEL

EHA Library, Vasiliki Antonopoulou, 4161892

A SINGLE CENTER REAL-WORLD ANALYSIS:CLINICAL CHARACTERISTICS AND PREDICTION OF THROMBOSIS RISK IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA

EHA Library, Rong Fu, 4161893

SPLENECTOMY IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA AND PRE-HEPATIC PORTAL HYPERTENSION

EHA Library, Vitalii Latyshev, 4161894

TREATMENT OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA PATIENTS WITH COMPLEMENT INHIBITORS - EXPERIENCE OF A SINGLE CENTER

EHA Library, Jaroslav Cermak, 4161895

REAL-WORLD EFFECTIVENESS OF RAVULIZUMAB IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: THE US POLESTAR CHART REVIEW STUDY

EHA Library, David Dingli, 4161896

FEMALE GENDER IS PROBABLY ASSOCIATED WITH WORSE HEMATOLOGIC RESPONSE TO C5 INHIBITORS IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA

EHA Library, Vitalii Latyshev, 4161897

COMPLICATIONS IN THE MEDIUM AND LONG TERM OF ACQUIRED APLASTIC ANEMIA IN ADULTS N. ZATOUT, H. HAMOUDA. HEMATOLOGY DEPARTMENT - UNIVERSITY HOSPITAL OF SÉTIF, ALGERIA.

EHA Library, zatout nisrine, 4161899

CLINICAL FEATURES AND OUTCOMES OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA PATIENTS TREATED WITH ECULIZUMAB IN TAIWAN: A MULTICENTER RETROSPECTIVE ANALYSIS

EHA Library, Hsing-Yu Lin, 4161901

MANAGEMENT OF A COMPLEX CASE OF ACTIVATED PI3KΔ SYNDROME-1 (APDS-1) IMPROVED BY LENIOLISIB: A CASE REPORT

EHA Library, Panagiotis Dolgyras, 4161902

PURE RED CELL APLASIA FOLLOWING COVID-19: CLINICAL INSIGHTS AND TREATMENT OUTCOMES

EHA Library, Shehab Fareed Abdelgabber, 4161903

EFFICACY OF RITUXIMAB PLUS GLUCOCORTICOIDS FOR PLATELET TRANSFUSION REFRACTORINESS IN SERIOUS APLASTIC ANEMIA

EHA Library, Jinbo Huang, 4161904

EFFICACY OF SCREENING FOR PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA - REAL-WORLD EXPERIENCE

EHA Library, Ana Boban, 4161905

CLINICAL STUDY ON AUTOLOGOUS STEM CELL TRANSPLANTATION FOR THE TREATMENT OF RETINOBLASTOMA

EHA Library, Yuan Sun, 4161906

INVESTIGATING THE MECHANISMS OF BUSHEN SHENGXUE DECOCTION COMBINED WITH CYCLOSPORINE AND STANOZOLOL TABLETS IN TREATING APLASTIC ANEMIA VIA INTEGRATED METABOLOMICS AND 16S RRNA SEQUENCING: A SINGLE-ARM STUDY

EHA Library, Siyuan Cui, 4161907

OUTCOME OF IMMUNOSUPPRESSIVE THERAPY IN PATIENTS WITH ACQUIRED APLASTIC ANEMIA: EXPERIENCE FROM A LOW MIDDLE INCOME COUNTRY

EHA Library, Vineeta Gupta, 4161908

TWO CASES OF BONE MARROW FAILURE AFTER RADIOTHERAPY AND CHEMOTHERAPY IN FANCONI ANEMIA TYPE D1 WITH CONCOMITANT MEDULLOBLASTOMA AND LITERATURE REVIEW

EHA Library, Yuan Sun, 4161909

FROM MISDIAGNOSIS TO REVELATION: A COMPLEX CASE OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA PRESENTING AS REFRACTORY THROMBOCYTOPENIA

EHA Library, Pyrus Bhellum, 4161910

PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) AND MYELODYSPLASIA: A RETROSPECTIVE ANALYSIS FROM A HEMATOLOGY CENTER.

EHA Library, H Tilman Steinmetz, 4161911

OUTCOME OF PATIENTS OVER 50 YEARS OLD WITH ACQUIRED SEVERE APLASTIC ANEMIA INELIGIBLE FOR TRANSPLANT: A SINGLE-CENTER STUDY IN MEXICO CITY.

EHA Library, María Elena Monserrat Luna Pérez, 4161912

A NON-INTERVENTIONAL CLINICAL AUDIT STUDY INVESTIGATING DIAGNOSTIC EFFICIENCY FOR GAUCHER DISEASE

EHA Library, Colm Bradley, 4161913

SEVERE CONGENITAL NEUTROPENIA FROM A NOVEL MUTATION SER126LEU OF ELANE GENE: A CASE REPORT

EHA Library, Jing He, 4161914

THE ROLE OF SERUM IGM IN BCR SIGNALING AND DRUG RESISTANCE IN IGM-SECRETING B LYMPHOMAS

EHA Library, Palash Chandra Maity, 4161915

PHENOTYPING THE COAGULATION OF NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS WITH THROMBOMODULIN-MODIFIED THROMBIN GENERATION.

EHA Library, Emilie Chalayer, 4161916

CORRELATION OF EXPRESSION OF MAJOR ENZYMES IN NAD+ SYNTHESIS WITH OVERALL SURVIVAL IN MULTIPLE MYELOMA

EHA Library, Lara Crone, 4161917

IDENTIFICATION OF FEGFR2 AS A NEW THERAPEUTIC TARGET FOR K-RAS-MUTATED MYELOMA

EHA Library, Ichiro Hanamura, 4161918

LOW-DOSE INVOLVED-SITE RADIOTHERAPY (LD-ISRT) COMBINED WITH HDAC INHIBITORS AS A BRIDGE TO CAR T-CELL THERAPY IN HEAVILY PRETREATED RELAPSED/REFRACTORY MULTIPLE MYELOMA (MM) AND NON-HODGKIN LYMPHOMA (NHL) WITH EXTRAMEDULLARY OR EXTRANODAL INVOLVEMENT: A SINGLE-CENTER, INVESTIGATOR-INITIATED STUDY

EHA Library, yajing zhang, 4161919

AUTOMATED DETECTION AND COMPREHENSIVE SPATIAL PROFILING IN PLASMA CELL DYSCRASIAS

EHA Library, Anna Sozanska, 4161920

BREAKING THROUGH THE DARKNESS OF RESISTANCE IN MULTIPLE MYELOMA: HNRNPK AS A NEW HORIZONT IN TREATMENT

EHA Library, Álvaro Otero-Sobrino, 4161921

PLASMA SPHINGOLIPIDOMICS FOR EXPLORING PROGNOSTIC BIOMARKERS IN PATIENTS WITH MULTIPLE MYELOMA

EHA Library, Zekun Li, 4161922

EPIGENETIC MODIFICATIONS OF THE PHOX2A AND CDH2 GENES - NEW INSIGHTS INTO THE PATHOGENESIS OF MULTIPLE MYELOMA.

EHA Library, Karolina Łuczkowska, 4161923

THE BCMA NK CELL ENGAGER SAR'514 INDUCES MACROPHAGE-MEDIATED PHAGOCYTOSIS WHICH IS IMPROVED BY COMBINATION WITH EVORPACEPT, A CD47 BLOCKER, IN MULTIPLE MYELOMA

EHA Library, Alexandre Tang, 4161924

MRD-TESTING IN MULTIPLE MYELOMA IN BELGIUM: DATA FROM THE MMOVE PROJECT

EHA Library, Marleen Bakkus, 4161925

SPATIAL IDENTIFICATION OF NEURONAL FIBERS AND MICROENVIRONMENTAL CELLS IN MULTIPLE MYELOMA BONE MARROW BIOPSIES AND THEIR POTENTIAL INFLUENCE ON PLASMA CELL DISTRIBUTION

EHA Library, Ana Filipa Barahona, 4161926

RNA SEQUENCING-BASED DETECTION OF PLASMA CELL CLONALITY AND CLONOTYPES IN PATIENTS WITH MULTIPLE MYELOMA.

EHA Library, Anna Sergeeva, 4161927

COMBINING PIM-2 AND PARP1 INHIBITORS INDUCES MICA EXPRESSION ON MULTIPLE MYELOMA CELLS TO ACTIVATE NK CELLS THROUGH NKG2D BINDING

EHA Library, Rong Fu, 4161928

FASTER MYELOMA MONITORING USING MACHINE LEARNING FOR M-SPIKE PREDICTIO

EHA Library, Ehsan Malek, 4161929

T CELL EXHAUSTION IN MULTIPLE MYELOMA: IMMUNOLOGICAL DYSFUNCTION AND THERAPEUTIC IMPLICATIONS

EHA Library, Paula Piñero, 4161930

THE INFLUENCE OF VITAMIN 25(OH)D AND K2MK7 ON THE DEVELOPMENT OF MULTIPLE MYELOMA CELLS UNDER HYPOXIC/PHYSIOLOGICAL CONDITIONS.

EHA Library, Karolina Łuczkowska, 4161931

STING DRIVES MULTIPLE MYELOMA PROGRESSION VIA CELL CYCLE DYSREGULATION AND APOPTOSIS SUPPRESSION

EHA Library, chunlan huang, 4161932